|
05/12/2008 01:00 PM
|
|
Electrode Re-Implantation May Help Patients Who Don't Respond To Brain Stimulation For Parkinson's Disease
|
A study of seven patients with Parkinson's disease suggests that those who have poor results following implantation of electrodes to stimulate the brain may benefit from additional surgery to correct the electrode placement, according to a report in the May issue of Archives of Neurology, one of the JAMA/Archives journals.
|
|
05/09/2008 02:00 AM
|
|
Neuroscientist Paul M. Carvey, Ph.D., Recieves Bernard Sanberg Memorial Award For Parkinson's Disease Research
|
The American Society for Neural Therapy and Repair (ASNTR) has awarded The 2008 Bernard Sanberg Memorial Award for Brain Repair to neuroscientist Paul M. Carvey, PhD, dean of the Graduate College at Rush University, Chicago, Ill. The award, made at ASNTR's 15th Annual Meeting 2008 in Clearwater, Fla., recognizes outstanding research contributions in the field of neural therapy and repair.
|
|
05/02/2008 03:00 AM
|
|
New Guide Strives To Improve Care Of Neurological Conditions, UK
|
A ground-breaking guide aimed at promoting the benefits of specialist nurses in the care of people with long term neurological conditions is launched today.The important document results from a unique partnership between three of the UK's leading charities for neurological conditions, the MS Society, Epilepsy Action and the Parkinson's Disease Society, with the Department of Health, Royal College of Nursing and NHS National Workforce Projects.
|
|
04/30/2008 01:00 AM
|
|
Parkinson Transplants Survive At Least 16 Years
|
Transplanted cells can survive in the brain for over one and half decades. However, some of the transplanted cells developed Parkinson-like features which is very surprising. These are the main findings of a study on grafting of new neurons to the brain in patients with Parkinson's disease. The study, headed by a team of researchers from Lund University in collaboration with London scientists headed by Professor Tamas Revesz, has been published in a recent issue of Nature Medicine.
|
|
04/29/2008 02:00 AM
|
|
Cell-Based Therapy Shows Promise In Patients With Parkinson's Disease
|
A novel cell therapy using retinal pigment epithelial (RPE) cells attached to tiny gelatin bead microcarriers implanted in the brain can improve the symptoms of patients with moderate to advanced Parkinson's disease (PD).Rush University Medical Center neurosurgeon Dr. Roy A. E.
|
|
04/28/2008 01:00 AM
|
|
University Of Alabama Team Earns HudsonAlpha Innovation Prize
|
For their groundbreaking research on diseases of the nervous system, especially in relation to Parkinson's disease, the husband and wife team of Drs. Guy and Kim Caldwell has been awarded the first HudsonAlpha Prize for Outstanding Innovation in Life Sciences.The $20,000 prize, in addition to recognizing exceptional talent and research of superior merit, aims to raise awareness of biotechnology's burgeoning impact on Alabama's economic vitality.
|
|
04/18/2008 12:00 AM
|
|
Alseres Pharmaceuticals Expands Sites For The First Stage Of The ALTROPANE(R) Phase III Clinical Trial Program
|
Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) announced that seven sites for the first stage of the ALTROPANE(R) Parkinson's or Essential Tremor - 2 (POET-2) Phase III clinical trial program are now open for patient enrollment. ALTROPANE molecular imaging agent is an investigational, diagnostic drug developed by Alseres to enable doctors to distinguish Parkinsonian Syndromes from non-Parkinsonian Syndromes in patients with tremor.
|
|
04/17/2008 05:00 AM
|
|
Parkinson's Research Finds Different Mutations In A Single Gene Suggest That It Is Primarily An Inherited Genetic Disorder
|
Two new international studies by researchers at the Mayo Clinic site in Florida are rounding out the notion that Parkinson's disease is largely caused by inherited genetic mutations that pass through scores of related generations over hundreds, if not thousands of years.
|
|
04/17/2008 04:00 AM
|
|
Process Identified That May Help Treat Parkinson's, Spinal Cord Injuries
|
A new discovery by University of Minnesota researchers may lead to a better understanding of how the spinal cord controls how people walk. These insights could help lead to treatments for central nervous system maladies such as Parkinson's disease and spinal cord injuries.The study, headed by Joshua Puhl, Ph.D., and Karen Mesce, Ph.D.
|
|
04/16/2008 05:00 AM
|
|
Better Muscle Control, Worse Side Effects In Parkinson's Drugs Tradeoff
|
Compared to older drugs for Parkinson disease, a newer class of medications called dopamine agonists might be better at preventing some of the disabling muscle control problems associated with the disease and its treatment, a new review of recent studies concludes.
|
|
04/16/2008 04:00 AM
|
|
Buck Institute And Q Therapeutics Form Stem Cell Collaboration To Combat Parkinson's Disease
|
The Buck Institute for Age Research and Q Therapeutics, Inc. announced an agreement to collaborate on novel routes to combat Parkinson's disease. The Buck Institute and Q Therapeutics will use their expertise in differentiating stem cells to provide key cell types needed to study Parkinson's disease. These neural-lineage cell lines will be used to further research aimed at the use of various stem and progenitor cells as a potential treatment for Parkinson's disease.
|
|
04/16/2008 01:00 AM
|
|
Patients With Early Parkinson's Disease Show Better Symptom Control And Improvements In Daily Activities With Stalevo Than Levodopa/Carbidopa
|
A new study in patients with early Parkinson's disease demonstrates that Stalevo®(levodopa/carbidopa/entacapone) gives better symptom control1and greater improvements in activities of daily living1 than levodopa/carbidopa, the most widely-used current therapy.
|
|
04/16/2008 12:00 AM
|
|
Phreesia Announces Clinical Initiative To Better Manage Symptoms Of Parkinson's Disease
|
Phreesia, Inc., the Patient Check-In Company, has announced that it will integrate a new screening tool developed by researchers at Duke University Medical Center into its electronic patient intake process, thereby potentially enhancing the ability of doctors to identify and manage the debilitating symptoms of Parkinson's disease.
|
|
04/15/2008 07:00 AM
|
|
Phase 2 Clinical Trial On Inosine Funded By Michael J. Fox Foundation Award Of $5.6M
|
The Michael J. Fox Foundation announced a $5.6-million award to drive a Phase 2 clinical trial to investigate the potential of inosine - a naturally occurring chemical that gives rise to urate in the body - to slow or stop the progression of Parkinson's disease.The work is being funded under the Foundation's LEAPS (Linked Efforts to Accelerate Parkinson's Solutions) 2007 initiative. LEAPS 2007 was funded with a lead gift from the Edmond J.
|
|
04/15/2008 03:00 AM
|
|
Elevated Urate Levels May Slow The Progression Of Parkinson's Disease
|
Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson's disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public Health (HSPH) examined data from an earlier study and found that, among recently diagnosed Parkinson's patients, those with the highest urate levels had a significantly slower rate of disease progression during the two-year study period.
|
|
04/15/2008 01:00 AM
|
|
Department Of Consumer Protection Alerts Consumers To Recall Of NEUPRO Drug Patch, Connecticut
|
Consumers who use NEUPRO (rotigotine transdermal system) patches should contact their physicians immediately to receive further instructions on how to proceed with the use of this patch in light of the recent recall initiated by Schwarz Pharma, a company of the UCB Group. Consumers who use this product should not abruptly cease this therapy as sudden withdrawal may cause severe, even life threatening symptoms.
|
|
04/12/2008 12:00 AM
|
|
Status Of The E2007 (perampanel) Development Program
|
E2007 (perampanel) is a first-in-class, orally administered, highly selective non-competitive AMPA-type glutamate receptor antagonist, in development by Eisai for several indications, including Parkinson's disease, neuropathic pain, epilepsy, multiple sclerosis and migraine prophylaxis. The AMPA receptor is widely present in almost all excitatory neuronal synapses.
|
|
04/08/2008 01:00 PM
|
|
Parkinson's In Rats Treated Effectively With Reprogrammed Skin Cells
|
Scientists in the US made new brain cells by inserting reprogrammed adult skin cells into fetal mouse brains and then used them to reduce symptoms of Parkinson's disease in rats. While this is a long way from demonstrating such a method might be effective in humans, it brings that hope a step closer.
|
|
04/08/2008 07:00 AM
|
|
Potential Parkinson's Treatments Could Follow Identification Of Dopamine 'Mother Cells'
|
'Mother cells' which produce the neurons affected by Parkinson's disease have been identified by scientists, according to new research published in the journal Glia.The new discovery could pave the way for future treatments for the disease, including the possibility of growing new neurons, and the cells which support them, in the lab. Scientists hope these could then be transplanted into patients to counteract the damage caused by Parkinson's.
|
|
04/08/2008 04:00 AM
|
|
Parkinson's Symptoms Reduced By Reprogrammed Cells In Rats
|
Neurons derived from reprogrammed adult skin cells successfully integrated into fetal mouse brains and reduced symptoms in a Parkinson's disease rat model, according to a study published on April 7 in the online Early Edition of PNAS.
|
|
04/08/2008 02:00 AM
|
|
Wii Used In Parkinson's Study
|
It's Ingrid Bell's turn at bat. She steps up to the plate, awaiting the pitch. A 70-mph fastball soars toward her. She swings and connects with the ball.Foul ball! Everyone cheers for her anyway.This baseball game's not taking place on a field, and there's no real bat or ball to be seen. Mrs. Bell is playing the Nintendo Wii as part of her occupational therapy.
|
|
04/08/2008 02:00 AM
|
|
Early Diagnosis Of Neurodegenerative Disease On The Horizon
|
A new blood test that can give an early diagnosis of neurodegenerative disease and distinguish between Parkinson's and Alzheimer's disease could be launched this summer, reports Marina Murphy in SCI's Chemistry & Industry magazine.
|
|
04/07/2008 04:00 AM
|
|
Treating Parkinson's With Grafted Fetal Cells May Not Work In Long Term
|
A new study by scientists in the US suggests that grafting fetal cells into a diseased brain as a way to treat Parkinson's may not be effective in the long term because the disease is an ongoing process that eventually affects the new cells. The finding raises questions about the long term value of stem cell therapy in the treatment of Parkinson's.
|
|
04/05/2008 12:00 AM
|
|
Pieces Coming Together In Parkinson's, Cholesterol Puzzle
|
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.But that study could not answer the question of whether low LDL (low-density lipoprotein) levels were present in study participants before they were diagnosed with Parkinson's, or if they developed low LDL levels after being diagnosed.
|
